We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trial Tests Cancer Drug’s Ability To Reduce Respiratory Symptoms of COVID-19

News   Jul 30, 2020 | Original story from The Ohio State University Comprehensive Cancer Center

 
Trial Tests Cancer Drug’s Ability To Reduce Respiratory Symptoms of COVID-19
 
 
Advertisement
 

RELATED ARTICLES

New Brain Cell-Like Nanodevices Work together to Identify Mutations in Viruses

News

Researchers have built a new device that acts just like a brain cell.

READ MORE

182 Genes Identified That Regulate Interactions Between Cancer Cells and T Cells

News

Toronto scientists have mapped the genes allowing cancer cells to avoid getting killed by the immune system that paves the way for the development of immunotherapies that would be effective for larger patient populations and across different tumour types.

READ MORE

Nanoparticle “Trojan Horse” Triggers Cancer Cells To Self-Destruct

News

A research team at the Nanyang Technological University, Singapore has found a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE